Andrew Pearson

Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema

Peter A. Campochiaro, David M. Brown, Andrew Pearson et al. · Ophthalmology · 2012 · 508 citations

Pharmacy, Ophthalmology, Pharmaceutics +13

Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema

Peter A. Campochiaro, David M. Brown, Andrew Pearson et al. · Ophthalmology · 2011 · 404 citations

Pharmacy, Ophthalmology, Pharmaceutics +15

Quality of life in idiopathic intracranial hypertension at diagnosis

Kathleen B. Digre, Bonnie Bruce, Michael McDermott et al. · Neurology · 2015 · 108 citations · Full text

Medicine, Neurology, Ophthalmology +16

Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension

Michael Wall, Julie Falardeau, William A. Fletcher et al. · Neurology · 2015 · 89 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +16

The safety profile of long-term, high-dose intraocular corticosteroid delivery

Nancy M. Holekamp, M.A. Thomas, Andrew Pearson · American Journal of Ophthalmology · 2005 · 52 citations

Pharmacy, Ophthalmology, Drug Delivery +13